Efficacy Testing Market

Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharma, Cosmetics & Personal Care, Medical Devices, Consumer Products) and Region - Global Forecast to 2027

Report Code: BT 5932 Jul, 2022, by marketsandmarkets.com

[181 Pages Report] The global efficacy testing market is projected to reach USD 423 million by 2027 from USD 315 million in 2022, at a CAGR of 6.1% during the forecast period. Factors such as regulations for pharmaceutical and cosmetic products addressing the safety of the products are expected to drive the growth of the global market for efficacy testing in the coming years. In addition, the efficacy of the active pharmaceutical ingredient (API) is the key concern, the market considers the regulation and validation of pharmaceutical products, and numerous methods of preservative efficacy testing (PET) have been advanced over the decade by standards organizations, regulatory agencies, industry organizations and individual firms such as an international conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH) and good clinical practice (GCP). The main purpose of these regulatory bodies is to meet the good documentation standard and scientific soundness.

Efficacy Testing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact

The COVID-19 outbreak has made institutional and household disinfection increasingly important to prevent the spread of the disease. Many consumers responded by panic-buying disinfecting products to ensure that they can keep their homes virus-free. As a result, synthetic disinfectants ran out of stock at retail stores. In response, retailers restocked their shelves with green disinfectants. The EPA also added many natural disinfectants to its "approved" list for fighting COVID-19.

Government agencies announced special financial aid toward the development of preventive and curative drugs, the purchase of critical care medical devices, and the fast-track approval of diagnostic tests. Various organizations across the globe, such as the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, came together to accelerate and strengthen the efforts to fight the COVID-19 pandemic.

The pandemic has disrupted healthcare systems all over the world, with hospitals being overwhelmed due to the increasing influx of patients. Temporary hospitals were set up to deal with an increasing disease incidence. Hence, the spread of COVID-19 spurred a surge in demand for cleaning and disinfection products due to the growing awareness about hygiene, health, and safety.

Post COVID-19, the demand for surface disinfectants is expected to scale up due to the threat of the re-emergence of the virus. Considering these factors, the COVID-19 pandemic is expected to result in the emergence of new domestic players in the surface disinfectants market, which in turn, will boost the demand for disinfectant efficacy testing.

Efficacy Testing Market Dynamics

Driver: Rising adoption of quality by design approach

Since the introduction of Quality-by-Design (QbD) concepts, it has been accepted that quality of pharmaceutical products should be designed and built during the manufacturing process. Most of quality problems are related to the way in which a pharmaceutical product was designed. A poor-designed pharmaceutical product will show poor safety and efficacy, no matter how many tests or analyses have been done to verified its quality. Thus, QbD begins with the recognition that quality will not be improved by merely increasing testing of pharmaceutical products. In other words, quality must be built into the product.

Restraint: Adverse effects of chemical disinfectants

Most of the chemical disinfectants currently available in the market have toxic properties. For example, sodium hypochlorite is an effective treatment against blood-borne pathogens but is also highly corrosive and a respiratory irritant, which makes it dangerous for cleaning personnel and building occupants as it causes damage to many surfaces and is toxic when released into the environment. The improper use of these disinfectants can cause environmental hazards and be harmful to patients exposed to them. Disinfectants sold in the US need to be registered with the Environmental Protection Agency (EPA), which classifies these solutions as pesticides; they are regulated under the FIFRA. There is no green certificate currently available for disinfectants in the market.

Due to a growing end-user population demanding greener solutions, the use of disinfectants is becoming limited, with their use being restricted to limited non-critical items and in lower amounts. Manufacturers are now being forced to develop newer and greener alternatives that are less corrosive to the human eyes, such as butyl-free, pH-neutral quaternary, and hydrogen peroxide-based disinfectants. In line with this, in 2021, Clorox Healthcare launched the new Clorox Healthcare Versa-Sure Cleaner Disinfectant Wipes that are alcohol-free.

Opportunity: Emerging countries in Asia Pacific region

Emerging economies, such as India, Brazil, and South Africa, offer significant opportunities for players in the efficacy testing markets. The growing need for advanced healthcare services in these economies is mainly driven by the rapidly increasing aging population and the rising number of patient volumes, growing per capita income, and rising awareness. Also, countries such as India have a huge population base, and these markets are home to a large patient base. Healthcare infrastructural improvements, such as the establishment of new facilities, have been a key trend in emerging markets, alongside rising awareness on the sterilization of medical products.

By service type, the disinfectant efficacy testing segment accounted for the largest share of the efficacy testing market in 2021.

Based on the product, the efficacy testing market is segmented into antimicrobial/preservative efficacy testing (AET/PET) and disinfectant efficacy testing. The disinfectant efficacy testing segment dominated this market in 2021. Rising awareness of environmental & personal hygiene has resulted in the increasing production and use of surface disinfectants. Also, technological advancements and rising R&D investments by key players to deliver novel technologies in the market are factors driving the growth of the segment.

By application, the pharmaceutical manufacturing applications segment accounted for the largest share of the efficacy testing market in 2021.

On the basis of application the efficacy testing market is segmented into pharmaceutical manufacturing applications, cosmetics and personal care product applications, consumer product applications, and medical device applications. The pharmaceutical manufacturing applications segment dominated this market in 2021 and is estimated to grow at the highest CAGR during the forecast period. A tremendous amount of analytical testing is required to support a product from discovery, development, and clinical trials, through manufacturing and marketing. The global competitive environment is compelling these companies to continuously conduct testing—or opt for testing services—throughout the development phases to increase the quality and efficacy of the products. However, the added costs and the time required place a burden on companies, prompting them to outsource testing. Outsourcing analytical testing services as a model and strategy allows companies to maintain the flexibility of internal resources and utilize technical capabilities not available in-house.

North America accounted for the largest share of the efficacy testing market in 2021.

In 2021, North America accounted for the largest share of the efficacy testing market. The major factors driving the growth of the North American efficacy testing services market include the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceuticals and cosmetic companies in the region. Also, most of the world's leading corporations are headquartered in the area or have a strong presence in this market, and others have also concentrated on expanding to improve their scope and capabilities.

Efficacy Testing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The prominent players in this market are Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

:

Report Metric

Details

Market size available for years

2019–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Service type, application, and region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK), BioScience Laboratories, Inc. (US), ALS Limited (Australia), Microchem Laboratory (US), Oxford Biosciences Ltd. (UK), Abbott Analytical (Australia), Helvic Laboratories (a Tentamus Company, UK), Honeyman Group Limited (UK), Danish Technological Institute (DTI, Denmark), and BluTest Laboratories Limited (UK)

The research report categorizes the efficacy testing market into the following segments and subsegments:

Service Type

  • Antimicrobial/ Preservative Efficacy Testing
    • Traditional test methods
    • Rapid test methods
  • Disinfectant Efficacy Testing
    • Surface test methods
    • Suspension test methods

Application

  • Pharmaceutical Manufacturing Applications
  • Cosmetics And Personal Care Product Applications
  • Consumer Product Applications
  • Medical Device Applications

Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Recent Developments

  • In 2021, Eurofins Scientific acquired bioskin GmbH (Germany), a dermatology-specific CRO, to strengthen Eurofins’ leadership position in cosmetic product testing.
  • In 2021, Intertek Group plc expanded the company’s Health, Environmental, and Regulatory Consultancy business lines in Spain and Russia.
  • In 2020, 3M launched the TB Quat Disinfectant Ready-to-use Cleaner.
  • In 2020, Ecolab acquired Holchem Group to strengthen its hygiene and cleaning products and services portfolio for the food & beverage, food service, and hospitality industries.
  • In 2019, Diversey Holdings Ltd. announced a strategic alliance in the North American industrial & institutional cleaning market. This partnership is focused on providing solutions for complete facility disinfection, cleaning, and air care for specific applications.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH APPROACH
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primary sources
                               FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                    2.1.2.2 Key industry insights
    2.2 MARKET SIZE ESTIMATION
           FIGURE 2 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
           FIGURE 3 EFFICACY TESTING MARKET: FINAL CAGR PROJECTIONS
           FIGURE 4 EFFICACY TESTING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           FIGURE 5 EFFICACY TESTING MARKET: SEGMENTAL ASSESSMENT
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS
    2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 36)
    FIGURE 7 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 8 EFFICACY TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 REGIONAL SNAPSHOT OF EFFICACY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 39)
    4.1 EFFICACY TESTING MARKET OVERVIEW
           FIGURE 10 GROWING PREFERENCE FOR OUTSOURCING EFFICACY TESTING TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: EFFICACY TESTING MARKET, BY APPLICATION AND COUNTRY (2021)
           FIGURE 11 PHARMACEUTICAL MANUFACTURING APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
    4.3 GEOGRAPHICAL SNAPSHOT OF EFFICACY TESTING MARKET
           FIGURE 12 CHINA TO WITNESS HIGHEST GROWTH RATE FROM 2022 TO 2027
    4.4 EFFICACY TESTING MARKET, BY REGION
           FIGURE 13 NORTH AMERICA TO DOMINATE MARKET IN 2027
    4.5 EFFICACY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
           FIGURE 14 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 43)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 15 EFFICACY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability
                               5.2.1.1.1 Growing focus on contamination control
                               5.2.1.1.2 Increasing concerns over product stability
                    5.2.1.2 Growing preference for outsourcing efficacy testing
                    5.2.1.3 Rising adoption of quality by design approach
                    5.2.1.4 Stringent regulations for use of surface disinfectants
                    5.2.1.5 Growing awareness of sanitization and hygiene due to spread of COVID-19
           5.2.2 RESTRAINTS
                    5.2.2.1 Adverse effects of chemical disinfectants
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging countries in Asia Pacific
           5.2.4 CHALLENGES
                    5.2.4.1 Time-consuming process
    5.3 REGULATORY ANALYSIS
           5.3.1 DISINFECTANT EFFICACY TESTING
           5.3.2 ANTIMICROBIAL EFFICACY TESTING
    5.4 IMPACT OF COVID-19 ON EFFICACY TESTING SERVICES
    5.5 PRICING ANALYSIS
           TABLE 1 PRICE OF SURFACE DISINFECTANT PRODUCTS (2022)
    5.6 PATENT ANALYSIS
    5.7 TRADE ANALYSIS
           5.7.1 TRADE ANALYSIS FOR DISINFECTANTS
                    TABLE 2 IMPORT DATA FOR DISINFECTANTS, BY COUNTRY, 2018–2022 (USD MILLION)
                    TABLE 3 EXPORT DATA FOR DISINFECTANTS, BY COUNTRY, 2018–2022 (USD MILLION)
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 16 VALUE CHAIN ANALYSIS: EFFICACY TESTING MARKET
    5.9 ECOSYSTEM ANALYSIS
           FIGURE 17 SURFACE DISINFECTANTS MARKET: ECOSYSTEM ANALYSIS
           TABLE 4 ROLE IN ECOSYSTEM
    5.10 PORTER’S FIVE FORCES ANALYSIS
           TABLE 5 EFFICACY TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT OF NEW ENTRANTS
           5.10.2 THREAT OF SUBSTITUTES
           5.10.3 BARGAINING POWER OF BUYERS
           5.10.4 BARGAINING POWER OF SUPPLIERS
           5.10.5 DEGREE OF COMPETITION
    5.11 TECHNOLOGY ANALYSIS

6 EFFICACY TESTING MARKET, BY SERVICE TYPE (Page No. - 57)
    6.1 INTRODUCTION
           TABLE 6 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
    6.2 DISINFECTANT EFFICACY TESTING
           TABLE 7 DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 8 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 9 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 10 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 11 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 12 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           6.2.1 SURFACE TEST METHOD
                    6.2.1.1 Surface test method segment to account for larger share of disinfectant efficacy testing market
                               TABLE 13 SURFACE TEST METHOD MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 14 NORTH AMERICA: SURFACE TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 15 EUROPE: SURFACE TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 16 APAC: SURFACE TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 SUSPENSION TEST METHOD
                    6.2.2.1 Suspension test method is typically performed by researchers during development stage of disinfectants
                               TABLE 17 SUSPENSION TEST METHOD MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 18 NORTH AMERICA: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 19 EUROPE: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 20 APAC: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING
           TABLE 21 EUROFINS SCIENTIFIC AET TEST PROTOCOL
           TABLE 22 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 23 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 24 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 25 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 26 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 27 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           6.3.1 TRADITIONAL TEST METHOD
                    6.3.1.1 Traditional test method segment to dominate AET/PET market
                               TABLE 28 TRADITIONAL TEST METHOD MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.3.2 RAPID TEST METHOD
                    6.3.2.1 Regulatory uncertainties restraining adoption of rapid microbial methods
                               TABLE 29 RAPID TEST METHOD MARKET, BY REGION, 2020–2027 (USD MILLION)

7 EFFICACY TESTING MARKET, BY APPLICATION (Page No. - 68)
    7.1 INTRODUCTION
           TABLE 30 EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 PHARMACEUTICAL MANUFACTURING APPLICATIONS
           7.2.1 INCREASING FOCUS ON ENSURING QUALITY OF DRUGS TO DRIVE SEGMENT GROWTH
                    TABLE 31 EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 32 NORTH AMERICA: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 33 EUROPE: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 34 APAC: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS
           7.3.1 EFFICACY TESTING IS AN ESSENTIAL PART OF STABILITY TESTING REGIMEN OF COSMETICS
                    TABLE 35 EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 36 NORTH AMERICA: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 37 EUROPE: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 38 APAC: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 CONSUMER PRODUCT APPLICATIONS
           7.4.1 GROWING FOCUS ON HEALTHY ENVIRONMENT IN HOMES AND INDUSTRIAL FACILITIES TO DRIVE SEGMENT GROWTH
                    TABLE 39 EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 40 NORTH AMERICA: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 41 EUROPE: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 42 APAC: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 MEDICAL DEVICE APPLICATIONS
           7.5.1 IMPOSITION OF STRINGENT GOVERNMENT REGULATIONS TO DRIVE SEGMENT GROWTH
                    TABLE 43 EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 44 NORTH AMERICA: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 45 EUROPE: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 46 APAC: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)

8 EFFICACY TESTING MARKET, BY REGION (Page No. - 77)
    8.1 INTRODUCTION
           TABLE 47 EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.2 NORTH AMERICA
           FIGURE 18 NORTH AMERICA: EFFICACY TESTING MARKET SNAPSHOT
           TABLE 48 NORTH AMERICA: EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 49 NORTH AMERICA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
           TABLE 50 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 51 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 52 NORTH AMERICA: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.2.1 US
                    8.2.1.1 US to dominate North American efficacy testing market during forecast period
                               TABLE 53 US: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 54 US: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 55 US: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.2.2 CANADA
                    8.2.2.1 Government initiatives to drive market growth in Canada
                               TABLE 56 CANADA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 57 CANADA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 58 CANADA: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.3 EUROPE
           TABLE 59 EUROPE: EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 60 EUROPE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
           TABLE 61 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 62 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 63 EUROPE: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.1 GERMANY
                    8.3.1.1 Germany to account for largest share in European market
                               TABLE 64 GERMANY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 65 GERMANY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 66 GERMANY: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.2 FRANCE
                    8.3.2.1 High demand for cosmetics in France to drive market growth
                               TABLE 67 FRANCE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 68 FRANCE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 69 FRANCE: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.3 UK
                    8.3.3.1 Efficacy testing market in UK is primarily driven by enforcement of regulatory and industry standards
                               TABLE 70 UK: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 71 UK: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 72 UK: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.4 ITALY
                    8.3.4.1 Increasing pharmaceutical production in Italy to drive market growth
                               TABLE 73 ITALY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 74 ITALY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 75 ITALY: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.5 SPAIN
                    8.3.5.1 Rising R&D expenditure to boost market growth in Spain
                               TABLE 76 SPAIN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 77 SPAIN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 78 SPAIN: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.3.6 REST OF EUROPE
                    TABLE 79 ROE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 80 ROE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                    TABLE 81 ROE: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.4 ASIA PACIFIC
           FIGURE 19 ASIA PACIFIC: EFFICACY TESTING MARKET SNAPSHOT
           TABLE 82 APAC: EFFICACY TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 83 APAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
           TABLE 84 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 85 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 86 APAC: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.4.1 CHINA
                    8.4.1.1 China to dominate Asia Pacific market
                               TABLE 87 CHINA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 88 CHINA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 89 CHINA: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.4.2 JAPAN
                    8.4.2.1 Rising R&D investments to drive market growth in Japan
                               TABLE 90 JAPAN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 91 JAPAN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 92 JAPAN: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.4.3 INDIA
                    8.4.3.1 Growing pharmaceutical industry in India to drive market growth
                               TABLE 93 INDIA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 94 INDIA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                               TABLE 95 INDIA: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.4.4 REST OF ASIA PACIFIC
                    TABLE 96 ROAPAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                    TABLE 97 ROAPAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                    TABLE 98 ROAPAC: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.5 REST OF THE WORLD
           TABLE 99 ROW: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
           TABLE 100 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 101 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2020–2027 (USD MILLION)
           TABLE 102 ROW: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           TABLE 103 ROW: EFFICACY TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
           8.5.1 LATIN AMERICA
                    8.5.1.1 Increasing pharmaceutical R&D expenditure to drive market growth in Latin America
                               TABLE 104 LATAM: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 105 LATAM: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
           8.5.2 MIDDLE EAST AND AFRICA
                    8.5.2.1 UAE has emerged as key market in MEA region
                               TABLE 106 MEA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020–2027 (USD MILLION)
                               TABLE 107 MEA: EFFICACY TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 104)
    9.1 OVERVIEW
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
           FIGURE 20 KEY DEVELOPMENTS IN EFFICACY TESTING MARKET, 2019–2022
    9.3 MARKET SHARE ANALYSIS
           FIGURE 21 EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2021
           TABLE 108 EFFICACY TESTING MARKET: DEGREE OF COMPETITION
    9.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    9.5 COMPANY EVALUATION QUADRANT
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
    9.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 STARTING BLOCKS
           9.6.3 RESPONSIVE COMPANIES
           9.6.4 DYNAMIC COMPANIES
    9.7 FOOTPRINT ANALYSIS OF COMPANIES
           9.7.1 SERVICE FOOTPRINT OF COMPANIES
                    TABLE 109 SERVICE FOOTPRINT OF COMPANIES: EFFICACY TESTING MARKET (2021)
           9.7.2 REGIONAL FOOTPRINT OF COMPANIES
                    TABLE 110 REGIONAL FOOTPRINT OF COMPANIES: EFFICACY TESTING MARKET (2021)
    9.8 COMPETITIVE SCENARIO
           TABLE 111 PRODUCT LAUNCHES
           TABLE 112 DEALS
           TABLE 113 OTHER DEVELOPMENTS

10 COMPANY PROFILES (Page No. - 116)
     10.1 EFFICACY TESTING SERVICE PROVIDERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             10.1.1 EUROFINS SCIENTIFIC
                       TABLE 114 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                       FIGURE 25 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
             10.1.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
                       TABLE 115 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
                       FIGURE 26 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
             10.1.3 WUXI APPTEC
                       TABLE 116 WUXI APPTEC: BUSINESS OVERVIEW
                       FIGURE 27 WUXI APPTEC: COMPANY SNAPSHOT (2021)
             10.1.4 SGS SA
                       TABLE 117 SGS SA: BUSINESS OVERVIEW
             10.1.5 INTERTEK GROUP PLC
                       TABLE 118 INTERTEK GROUP PLC: BUSINESS OVERVIEW
                       FIGURE 28 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2021)
             10.1.6 MICROCHEM LABORATORY
                       TABLE 119 MICROCHEM LABORATORY: BUSINESS OVERVIEW
             10.1.7 ACCUGEN LABORATORIES, INC.
                       TABLE 120 ACCUGEN LABORATORIES, INC.: BUSINESS OVERVIEW
             10.1.8 PACIFIC BIOLABS
                       TABLE 121 PACIFIC BIOLABS: BUSINESS OVERVIEW
             10.1.9 NORTH AMERICAN SCIENCE ASSOCIATES
                       TABLE 122 NORTH AMERICAN SCIENCE ASSOCIATES: BUSINESS OVERVIEW
             10.1.10 TOXIKON
                       TABLE 123 TOXIKON: BUSINESS OVERVIEW
             10.1.11 BIOSCIENCE LABORATORIES, INC.
                       TABLE 124 BIOSCIENCE LABORATORIES, INC.: BUSINESS OVERVIEW
             10.1.12 CONSUMER PRODUCT TESTING COMPANY (CPTC)
                       TABLE 125 CONSUMER PRODUCT TESTING COMPANY (CPTC): BUSINESS OVERVIEW
             10.1.13 ALMAC GROUP
                       TABLE 126 ALMAC GROUP: BUSINESS OVERVIEW
             10.1.14 MSL SOLUTION PROVIDERS
                       TABLE 127 MSL SOLUTION PROVIDERS: BUSINESS OVERVIEW
             10.1.15 NELSON LABORATORIES, LLC (A SOTERA HEALTH COMPANY)
                       TABLE 128 NELSON LABORATORIES, LLC: BUSINESS OVERVIEW
             10.1.16 ALS LIMITED
                       TABLE 129 ALS LIMITED: BUSINESS OVERVIEW
             10.1.17 ABBOTT ANALYTICAL
                       TABLE 130 ABBOTT ANALYTICAL: BUSINESS OVERVIEW
             10.1.18 BLUTEST LABORATORIES LIMITED
                       TABLE 131 BLUTEST LABORATORIES LIMITED: BUSINESS OVERVIEW
             10.1.19 LUCIDEON
                       TABLE 132 LUCIDEON: BUSINESS OVERVIEW
             10.1.20 HELVIC LABORATORIES (A TENTAMUS COMPANY)
                       TABLE 133 HELVIC LABORATORIES: BUSINESS OVERVIEW
     10.2 MANUFACTURERS OF DISINFECTANTS
             10.2.1 PROCTER & GAMBLE
                       TABLE 134 PROCTER & GAMBLE: BUSINESS OVERVIEW
                       FIGURE 29 PROCTER & GAMBLE: COMPANY SNAPSHOT (2021)
             10.2.2 THE CLOROX COMPANY
                       TABLE 135 THE CLOROX COMPANY: BUSINESS OVERVIEW
                       FIGURE 30 THE CLOROX COMPANY: COMPANY SNAPSHOT (2021)
             10.2.3 3M
                       TABLE 136 3M: BUSINESS OVERVIEW
                       FIGURE 31 3M: COMPANY SNAPSHOT (2021)
             10.2.4 RECKITT BENCKISER GROUP PLC
                       TABLE 137 RECKITT BENCKISER GROUP PLC: BUSINESS OVERVIEW
                       FIGURE 32 RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT (2021)
             10.2.5 ECOLAB
                       TABLE 138 ECOLAB: BUSINESS OVERVIEW
                       FIGURE 33 ECOLAB: COMPANY SNAPSHOT (2021)
             10.2.6 STERIS
                       TABLE 139 STERIS: BUSINESS OVERVIEW
                       FIGURE 34 STERIS: COMPANY SNAPSHOT (2021)
             10.2.7 CANTEL MEDICAL
                       TABLE 140 CANTEL MEDICAL: BUSINESS OVERVIEW
                       FIGURE 35 CANTEL MEDICAL: COMPANY SNAPSHOT (2021)
             10.2.8 DIVERSEY HOLDINGS LTD.
                       TABLE 141 DIVERSEY HOLDINGS LTD.: BUSINESS OVERVIEW
                       FIGURE 36 DIVERSEY HOLDINGS LTD.: COMPANY SNAPSHOT (2021)
             10.2.9 CARROLLCLEAN
                       TABLE 142 CARROLLCLEAN: BUSINESS OVERVIEW
             10.2.10 PAUL HARTMANN AG
                       TABLE 143 PAUL HARTMANN AG: BUSINESS OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 175)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 AVAILABLE CUSTOMIZATIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global efficacy testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the efficacy testing market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

This research study involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies’ house documents, investor presentations, and SEC filings of companies. The secondary sources referred to for this research study include publications from government sources, such as the European Federation of Pharmaceutical Industries and Association, European Trade Association, Environmental Protection Agency, International Journal of Environmental Research and Public Health, Pharmaceutical Research and Manufacturers of America, United States Pharmacopeia, European Pharmacopoeia, World Health Organization, and US Food and Drug Administration. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the efficacy testing market. It was also used to obtain important information about the key players and market classification, segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Data

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

Primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of companies providing efficacy testing services, key opinion leaders, and suppliers. Primary sources from the demand side include scientists, researchers, microbiologists, and other related key executives from pharmaceutical and biotechnology companies.

Primary research was used in this report to:

  • Validate the market segmentation defined through service portfolio assessment of leading players in the efficacy testing market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the efficacy testing market and their market share/ranking

Efficacy Testing Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the efficacy testing market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the efficacy testing market

Report Objectives

  • To define, describe, and forecast the efficacy testing market by service type, application, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, collaborations, and expansions in the efficacy testing market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the efficacy testing market into specific countries for the LATAM and MEA regions
Efficacy Testing Market Size,  Share & Growth Report
Report Code
BT 5932
Published ON
Jul, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved